We are delighted to announce that we have successfully passed an inspection for our Pharmacovigilance system.
This was triggered due to us managing Pharmacovigilance for a company in North America, one of number of clients we maintain PV for. The inspection took place in January 2016 and there were no critical findings.
CEO Alan White commented on the news:
“We are really pleased that the confidence we had in our own system has been reinforced by this inspection. We get audited many times each year by our PV clients but this was our first health agency inspection and we have passed it with no critical findings. We will continue to invest in our system, our people, training and our QMS to ensure that we continue to improve.
We believe this great news further reinforces the fact that we are a safe choice for companies that wish to outsource some or all of their Pharmacovigilance activities, global or local, particularly as we complement them with our Medical Writing, Regulatory Affairs and Translation services”.